Currently out of the existing stock ratings of Heather Behanna, 16 are a BUY (55.17%), 13 are a HOLD (44.83%).

Heather Behanna

Work Performance Price Targets & Ratings Chart

Analyst Heather Behanna, carries an average stock price target met ratio of 95.83% that have a potential upside of 60.33% achieved within 491 days. Previously, Heather Behanna worked at WEDBUSH.

Heather Behanna’s has documented 58 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ALXN, Alexion Pharmaceuticals at 12-Dec-2016.

Wall Street Analyst Heather Behanna

Analyst best performing recommendations are on TTPH (TETRAPHASE PHARMACEUTICALS).
The best stock recommendation documented was for SRPT (SAREPTA THERAPEUTICS) at 5/20/2015. The price target of $25 was fulfilled within 1 day with a profit of $1.24 (4.73%) receiving and performance score of 47.26.

Average potential price target upside

of $146.8 (155.98%) on NVAX (NOVAVAX).
of $78.2 (23.01%) on TTPH (TETRAPHASE PHARMACEUTICALS).
of $16.1 (73.21%) on SRPT (SAREPTA THERAPEUTICS).

SRPT Sarepta Therapeutics MRTX Mirati Ther PTCT PTC Therapeutics AKAO Achaogen NVAX Novavax TTPH Tetraphase Pharmaceuticals ALXN Alexion Pharmaceuticals PRTA Prothena plc

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Gil Blum (NEEDHAM)